These data indicate an improved insulin sensitivity in vivo. Importantly, after GLP-1RA treatment, serum adiponectin levels in MetS women increased significantly (Table 3 and Figure 6D), while serum GPHB5 levels decreased significantly (Table 3 and Figure 6E). This evidence concerns the gene GPHB5 and metabolic syndrome.